5 Stocks Poised for Breakouts
Durata Therapeutics
Another stock that's trending within range of triggering a near-term breakout trade is Durata Therapeutics (DRTX), a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. This stock is off to a decent start for the bulls in 2013, with shares up 12%.
If you take a look at the chart for Durata Therapeutics, you'll notice that this stock has started to bounce higher today right above its 50-day moving average at $7.99 a share with above-average volume. This bounce is quickly pushing shares of DRTX within range of triggering a near-term breakout trade.
>>4 Big Stocks to Trade (or Not)
Market players should now look for long-biased trades in DRTX if it manages to break out above some near-term overhead resistance levels at $9.05 to $9.27 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 31,302 shares. If that breakout triggers soon, then DRTX will set up to re-test or possibly take out its next major overhead resistance level at its all-time high of $10.63 a share. Any move above $10.63 would then push shares of DRTX into new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $13 to $15 a share. Traders can look to buy DRTX off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $7.99 a share. One could also buy off strength once DRTX clears those breakout levels with volume and then simply use a stop that sits a few percentage points below your entry point.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV